MARLBOROUGH, Mass., April 23, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Dru
Source: www.prnewswire.com
Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge Aortic Valve System. The transcatheter aortic valve replacement (TAVR) technology is approved for patients with severe aortic stenosis who are considered at high risk for surgical valve replacement through open heart surgery. The company initiated a controlled launch of the valve system in Europe in March and in the coming weeks will commence in the U.S.
